While Burger King hasn't officially confirmed it, customers in New York are beginning to notice that salads are among the items missing from its menu.
Social media users and several Burger King restaurant managers said that the fast-food chain had stopped offering salads. Several Burger King locations in Queens and Long Island have already removed salads, of any variety, from their menu boards.
As of January, a Chicken Garden Salad and a side salad were available.
Four New York-area restaurant managers confirmed that salads were "gone" and "won't be coming back," with one of them quipping that water is the healthiest thing on their menu.
Carrols Restaurant Group, which operates more than 1,000 restaurants and is the largest Burger King franchisee in the US, announced recently that it is reducing the number of chicken nuggets in its meals from 10 pieces to 8 pieces, without offering consumers a lower price.
Carrols explained that the move was in response to inflation and an alternative to raising prices.
The Whopper will be phased out from the chain's main discount menu, as well as from Two for $5 and Two for $6 specials.
According to RBI's CEO José Cil, the Whopper had been on the bargain menu "for far too long."
Burger King announced it would market the Whopper as a premium, "iconic" offering in the future.
Burger King may possibly eliminate single, double, and triple Whoppers as separate items and make changes to the original chicken sandwich with the new Ch'King sandwich becoming the chain's standard offering.


Trump Plans Diesel Tax Relief as Fuel Prices Hit Record Highs
UK House Prices Flat in September as Mortgage Rates Weigh
GSR Commits $100M to Hare Onchain Credit Vaults
3 clinical-grade skincare creams you really shouldn’t buy online
Securitize, LG CNS Partner on South Korea Tokenization
German Industrial Orders Plunge 10.6% in August
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
S&P 500 Hits Record High as AI Rally Lifts Wall Street
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Japan Real Wages Rise 1.5%, Supporting BOJ Rate Hikes
Australia Consumer Confidence Plunges as RBA Rate Hike Hits Households
Evernorth XRPN Nasdaq Listing Delayed to October 12
Sanofi, Regeneron Expand Drug Partnership in $8 Billion Deal
SpaceX Seeks $40 Billion for Nvidia AI Chips
Zcash Prepares for NU7 Upgrade as Zebra Gets Key Security Fixes
OKX Raises Fresh Funding at $25 Billion Valuation
RBI Raises Repo Rate to 5.50% in Hawkish Shift on Inflation Risks 



